Akso Health vs Callan JMB
AHG and CJMB side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHG and CJMB compare
Akso Health grew revenue faster over the last twelve months (−6.4% versus −13.8% for Callan JMB).
Akso Health keeps more of each dollar of sales as profit, with a net margin of −135% compared with −192% at Callan JMB.
Callan JMB scores higher on the StockData Score (8 against 7 for Akso Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHG | CJMB |
|---|---|---|
| Size and price | ||
| Market cap | – | $2.3M |
| Share price | $1.24 | $0.408 |
| Change, 1 year | −17.9% | −89.2% |
| Change, 5 years | −57.7% | – |
| Beta (5Y) | 0.53 | 0.32 |
| Employees | 12 | 20 |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 1 | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.5× |
| P/B | – | 3.4× |
| FCF yield | – | −202% |
| Fair value | – | $1.79 |
| Margin of safety | – | 77.2% |
| Growth | ||
| Revenue growth (TTM) | −6.4% (better) | −13.8% |
| Revenue growth, 5Y average | 51.1% | – |
| EPS growth (TTM) | −93.8% | – |
| Profitability | ||
| Gross margin | −0.08% | 39.9% (better) |
| Operating margin | −150% | −146% (better) |
| Net margin | −135% (better) | −192% |
| FCF margin | −92.5% (better) | −93.1% |
| Return on equity | −9.8% (better) | −300% |
| Return on invested capital | −16.1% (better) | −826% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 21.77 (better) | 1.30 |
| Altman Z-score | – | −8.51 |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.01% | 10.8% |
| Held by insiders | 0.00% | 68.5% |
| Insider net buying, 12 months | – | $165K |
| Short interest, % of float | – | 11.2% |
Go deeper
- AHG stock overview
- AHG income statement
- AHG valuation and score
- CJMB stock overview
- CJMB income statement
- CJMB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.